Medtronic (MDT) Tops Q1 EPS by 9c; Offers FY23 EPS Guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $92.13 -0.69%
Revenue Growth %: +5.3%
Financial Fact:
Selling, general, and administrative expense: 1.49B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.3%
Financial Fact:
Selling, general, and administrative expense: 1.49B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q1 EPS of $1.20, $0.09 better than the analyst estimate of $1.11. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.57 billion.
GUIDANCE:
Medtronic sees FY2024 EPS of $5.08-$5.16, versus the consensus of $5.05.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Amneal gets FDA approval for lanreotide injection, launches immediately
- Anthropic delays planned IPO from October to November - WSJ
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
